Nephros Inc. DEF 14A: Executive Compensation Details
Ticker: NEPH · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: NEPH
TL;DR
NEPH DEF 14A out: exec pay details for 2024, including equity awards.
AI Summary
Nephros Inc. filed its DEF 14A on April 30, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to key personnel, such as NEPH:FirstPeoMember and NEPH:SecondPeoMember, and their fair values at various stages, including grant date, year-end, and vesting dates.
Why It Matters
This filing provides transparency into how Nephros Inc. compensates its top executives, which can influence investor decisions and perceptions of the company's governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing disclosing executive compensation and does not inherently present new financial risks.
Key Players & Entities
- NEPHROS INC (company) — Filer
- NEPH:FirstPeoMember (person) — Executive
- NEPH:SecondPeoMember (person) — Executive
FAQ
What is the primary purpose of this DEF 14A filing for Nephros Inc.?
The primary purpose is to disclose information regarding the solicitation of proxies for the company's annual meeting of stockholders, including details on executive compensation, director nominations, and other corporate governance matters.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information in this filing primarily covers the fiscal year ending December 31, 2024.
Who are the named individuals whose compensation details are provided in the filing?
The filing refers to individuals identified as NEPH:FirstPeoMember and NEPH:SecondPeoMember, who are likely key executives or directors.
What types of equity awards are detailed in the filing?
The filing details equity awards granted during the applicable year, their fair value at grant date, their fair value as of the end of the prior fiscal year for awards that failed to meet vesting conditions, and the year-end fair value of outstanding and unvested equity awards.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 30, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 by NEPH:FirstPeoMember regarding NEPHROS INC (NEPH).